<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37693725</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Digital health solution for monitoring and surveillance of Amyotrophic Lateral Sclerosis in Brazil.</ArticleTitle><Pagination><StartPage>1209633</StartPage><MedlinePgn>1209633</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1209633</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1209633</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a complex and rare neurodegenerative disease given its heterogeneity. Despite being known for many years, few countries have accurate information about the characteristics of people diagnosed with ALS, such as data regarding diagnosis and clinical features of the disease. In Brazil, the lack of information about ALS limits data for the research progress and public policy development that benefits people affected by this health condition. In this context, this article aims to show a digital health solution development and application for research, intervention, and strengthening of the response to ALS in the Brazilian Health System. The proposed solution is composed of two platforms: the Brazilian National ALS Registry, responsible for the data collection in a structured way from ALS patients all over Brazil; and the Brazilian National ALS Observatory, responsible for processing the data collected in the National Registry and for providing a monitoring room with indicators on people diagnosed with ALS in Brazil. The development of this solution was supported by the Brazilian Ministry of Health (MoH) and was carried out by a multidisciplinary team with expertise in ALS. This solution represents a tool with great potential for strengthening public policies and stands out for being the only public database on the disease, besides containing innovations that allow data collection by health professionals and/or patients. By using both platforms, it is believed that it will be possible to understand the demographic and epidemiological data of ALS in Brazil, since the data will be able to be analyzed by care teams and also by public health managers, both in the individual and collective monitoring of people living with ALS in Brazil.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Barbalho, Fonseca, Fernandes, Henriques, Gil, Nagem, Lindquist, Lima, Santos, Paiva, Morais, Dourado J&#xfa;nior and Valentim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Barbalho</LastName><ForeName>Ingridy M P</ForeName><Initials>IMP</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fonseca</LastName><ForeName>Aleika L A</ForeName><Initials>ALA</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Informatics Engineering, Center for Informatics and Systems of the University of Coimbra, Universidade de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil</LastName><ForeName>Paulo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Informatics Engineering, Center for Informatics and Systems of the University of Coimbra, Universidade de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagem</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindquist</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Rio Grande do Norte Federal University, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Thaisa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Brazilian Ministry of Health, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Jo&#xe3;o Paulo Queiroz</ForeName><Initials>JPQ</Initials><AffiliationInfo><Affiliation>Advanced Nucleus of Technological Innovation (NAVI), Federal Institute of Education Science and Technology, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Jailton</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morais</LastName><ForeName>Antonio H F</ForeName><Initials>AHF</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourado J&#xfa;nior</LastName><ForeName>M&#xe1;rio E T</ForeName><Initials>MET</Initials><AffiliationInfo><Affiliation>Department of Integrated Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentim</LastName><ForeName>Ricardo A M</ForeName><Initials>RAM</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiological monitoring</Keyword><Keyword MajorTopicYN="N">health indicators</Keyword><Keyword MajorTopicYN="N">health information system</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">public policy</Keyword><Keyword MajorTopicYN="N">rare diseases</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37693725</ArticleId><ArticleId IdType="pmc">PMC10485256</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1209633</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. . Amyotrophic lateral sclerosis. Lancet. (2017) 390:2084&#x2013;98. 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. (2009) 4:1&#x2013;22. 10.1186/1750-1172-4-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F, Lunetta C, Banfi P, Rossi G, Fossati F, Marconi A, et al. . Pain in amyotrophic lateral sclerosis: a psychological perspective. Neurol Scie. (2012) 33:1193&#x2013;6. 10.1007/s10072-011-0888-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0888-6</ArticleId><ArticleId IdType="pubmed">22183268</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. . Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. (2013) 3:310&#x2013;22. 10.1016/S1474-4422(13)70036-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Damme PV, et al. . EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) revised report of an EFNS task force. Eur J Neurol. (2012) 3:360&#x2013;75. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. (2014) 13:1228&#x2013;40. 10.1016/S1474-4422(14)70167-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima SR, Gomes KB. Esclerose lateral amiotr&#xf3;fica e o tratamento com c&#xe9;lulas-tronco. Rev Bras Clin Med. (2010) 8:531&#x2013;7.</Citation></Reference><Reference><Citation>Cook SF, Rhodes T, Schlusser C, Han S, Chen C, Zach N, et al. . A descriptive review of global real world evidence efforts to advance drug discovery and clinical development in amyotrophic lateral sclerosis. Front Neurol. (2021) 11:12. 10.3389/fneur.2021.770001</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.770001</ArticleId><ArticleId IdType="pmc">PMC8606522</ArticleId><ArticleId IdType="pubmed">34819914</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. (2019) 32:771&#x2013;6. 10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, ChiA, Traynor BJ, et al. . Projected increase in amyotrophic lateral sclerosis from 2015 to (2040). Nat Commun. (2016) 7:12408. 10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Logroscino G, Boumdiene F, Labrunie A, Couratier P, Babron MC, et al. . Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Neurol. (2016). 3:229&#x2013;45. 10.1007/s10654-015-0090-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0090-x</ArticleId><ArticleId IdType="pubmed">26458931</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boumdiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. . Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. (2017) 46:57&#x2013;74. 10.1093/ije/dyw061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Front Degener. (2015) 16:65&#x2013;71. 10.3109/21678421.2014.971813</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.971813</ArticleId><ArticleId IdType="pmc">PMC4389704</ArticleId><ArticleId IdType="pubmed">25482100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Front Degener. (2014) 15:433&#x2013;9. 10.3109/21678421.2014.887119</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.887119</ArticleId><ArticleId IdType="pmc">PMC4587982</ArticleId><ArticleId IdType="pubmed">24597459</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. (2019) 52:93&#x2013;103. 10.1159/000493386</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>de Godoy Rousseff Prado L, Bicalho ICS, Vidigal-Lopes M, Ferreira CJA, Barbosa LSM, Gomez RS, et al. . Amyotrophic lateral sclerosis in Brazil: Case series and review of the Brazilian literature. Amyotroph Lateral Scler Front Degener. (2016) 5:282&#x2013;8. 10.3109/21678421.2016.1143011</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143011</ArticleId><ArticleId IdType="pubmed">26854959</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, et al. . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiat. (2008) 1:6&#x2013;11. 10.1136/jnnp.2006.104828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.104828</ArticleId><ArticleId IdType="pubmed">18079297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Horton DK, Kasarskis EJ, Tessaro E, Eisenberg MS, Laird S, et al. . CDC grand rounds: national amyotrophic lateral sclerosis (als) registry impact, challenges, and future directions. MMWR Morbidity and Mortality Weekly Report. (2017) 66:1379&#x2013;82. 10.15585/mmwr.mm6650a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6650a3</ArticleId><ArticleId IdType="pmc">PMC5751576</ArticleId><ArticleId IdType="pubmed">29267263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, McCormick A, MacKenzie A, OFerrall E, Venance S, Mah JK, et al. . The canadian neuromuscular disease registry: connecting patients to national and international research opportunities. Paediat Child Health. (2018) 2:20&#x2013;26. 10.1093/pch/pxx125</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pch/pxx125</ArticleId><ArticleId IdType="pmc">PMC5814813</ArticleId><ArticleId IdType="pubmed">29479275</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell RR, Zuchner S. MOVRNeuro muscular observational research, a unified data hub for neuromuscular diseases. Genetics in Medicine. (2019) 21:536&#x2013;8. 10.1038/s41436-018-0086-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-018-0086-5</ArticleId><ArticleId IdType="pubmed">29934516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosini A, Calabrese D, Avato FM, Catania F, Cavaletti G, Pera MC, et al. . The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage. Orphanet J Rare Dis. (2018) 13:176. 10.1186/s13023-018-0918-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-018-0918-z</ArticleId><ArticleId IdType="pmc">PMC6172847</ArticleId><ArticleId IdType="pubmed">30286784</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E Wallin AR Samuelsson K Press R Zachau A Ronnevi LO . The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Front Degener. (2018) 19:528&#x2013;37. 10.1080/21678421.2018.1497065</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId><ArticleId IdType="pubmed">30296856</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker KL, Rodrigues MJ, Watson B, Reilly C, Scotter EL, Brunton H, et al. . Establishment and 12-month progress of the New Zealand Motor Neurone disease registry. J Clinical Neurosci. (2019) 2:7&#x2013;11. 10.1016/j.jocn.2018.11.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2018.11.034</ArticleId><ArticleId IdType="pubmed">30473407</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbalho I, Valentim R, Jnior MD, Barros D, Jnior HP, Fernandes F, et al. . National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases. BMC Neurol. (2021) 21:269. 10.1186/s12883-021-02298-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02298-2</ArticleId><ArticleId IdType="pmc">PMC8259351</ArticleId><ArticleId IdType="pubmed">34229610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes-Jnior LC, Ferraz VEF, Lima RAG, Schuab SIPC, Pessanha RM, Luz GS, et al. . Health policies for rare disease patients: a scoping review. Int J Environ Res Public Health. (2022) 19:15174. 10.3390/ijerph192215174</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192215174</ArticleId><ArticleId IdType="pmc">PMC9690117</ArticleId><ArticleId IdType="pubmed">36429893</ArticleId></ArticleIdList></Reference><Reference><Citation>IBGE Brasil. 
IBGE - Instituto Brasileiro de Geografia e Estatistica. (2023). Available online at: https://www.ibge.gov.br/ (accessed April 13, 2023).</Citation></Reference><Reference><Citation>Dantas MNP. Souza DLBd, Souza AMGd, Aiquoc KM, Souza TAd, Barbosa IR. Fatores associados ao acesso precrio aos servios de sade no Brasil. Revista Brasileira de Epidemiologia. (2021) 24:e210004. 10.1590/1980-549720210004</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-549720210004</ArticleId><ArticleId IdType="pubmed">33331413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitombeira DF, Oliveira de. Pobreza e desigualdades sociais: tenses entre direitos, austeridade e suas implicaues na ateno primria. Cincia &amp; Sade Coletiva. (2020) 25:1699&#x2013;708. 10.1590/1413-81232020255.33972019</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1413-81232020255.33972019</ArticleId><ArticleId IdType="pubmed">32402023</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich-Neto F, Callegaro D, Dias-Tosta E, Silva HA, Ferraz ME, Lima JMBD, et al. . Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arquivos de Neuro-Psiquiatria. (2000) 9:607&#x2013;15. 10.1590/S0004-282X2000000400002</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2000000400002</ArticleId><ArticleId IdType="pubmed">10973098</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura MC, Casulari LA, Novaes MRCG. Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: a population based study. Amyotroph Lateral Scler Front Degener. (2016) 17:275&#x2013;81. 10.3109/21678421.2016.1140210</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1140210</ArticleId><ArticleId IdType="pubmed">26850047</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Costa CMD, Ori RB, Machado-Filho JA, Franco MTG, Diniz DLO, Giffoni SD, et al. . Amyotrophic lateral sclerosis: clinical analysis of 78 cases from Fortaleza (Northeastern Brazil). Arquivos de Neuro-Psiquiatria. (1999) 9:761&#x2013;74. 10.1590/S0004-282X1999000500006</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X1999000500006</ArticleId><ArticleId IdType="pubmed">10751910</ArticleId></ArticleIdList></Reference><Reference><Citation>Loureiro MPS, Gress CH, Thuler LCS, Alvarenga RMP, Lima JMB. Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro/Brazil. J Neurol Sci. (2012) 316:61&#x2013;6. 10.1016/j.jns.2012.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.01.029</ArticleId><ArticleId IdType="pubmed">22342397</ArticleId></ArticleIdList></Reference><Reference><Citation>Junior EL, Becker J, Schestatsky P, Rotta FT, Marrone CD, Gomes I. Prevalence of amyotrophic lateral sclerosis in the city of Porto Alegre, in Southern Brazil. Arq Neuropsiquiatr. (2013) 71:959&#x2013;62. 10.1590/0004-282X20130177</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20130177</ArticleId><ArticleId IdType="pubmed">24347016</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira RTGD, Santana GC, Gonalves MDJ, Fregonezi GADF, Vale SHDL, Leite-Lais L, et al. . A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to (2018). Amyotroph Lateral Scler Front Degener. (2023) 1:117&#x2013;24. 10.1080/21678421.2022.2102429</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2022.2102429</ArticleId><ArticleId IdType="pubmed">35916197</ArticleId></ArticleIdList></Reference><Reference><Citation>Comisso Nacional de Incorporao de TecnologiasCONITEC . Protocolo Cl-nico e Diretrizes Teraputicas da Esclerose Lateral AmiotrficaPCDT. Ministrio da Sade. (2021). Available online at: http://antigo-conitec.saude.gov.br/images/Consultas/Relatorios/2019/Relatorio_PCDT_Esclerose_Lateral_Amiotrofica.pdf (accessed April 13, 2023).</Citation></Reference><Reference><Citation>Gliklich RE, Dreyer NA, Leavy MB. Registries for Evaluating Patient Outcomes: A USERS GUIDE. 3rd edition. Rockville, MD: Agency for Healthcare Research and Quality; (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24945055</ArticleId></ArticleIdList></Reference><Reference><Citation>Srkzy A, Bushby K, Broud C, Lochmller H. 157th ENMC International Workshop: Patient registries for rare, inherited muscular disorders 25&#x2013;27 January (2008). Naarden, The Netherlands Neuromusc Disord. (2008) 18:997&#x2013;1001. 10.1016/j.nmd.2008.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2008.07.006</ArticleId><ArticleId IdType="pubmed">18948006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan L, Kaye W, Antao V, Mehta P, Muravov O, Horton DK, et al. . Preliminary results of national amyotrophic lateral sclerosis (ALS) registry risk factor survey data. PLoS ONE. (2016) 11:e0153683. 10.1371/journal.pone.0153683</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153683</ArticleId><ArticleId IdType="pmc">PMC4849726</ArticleId><ArticleId IdType="pubmed">27124833</ArticleId></ArticleIdList></Reference><Reference><Citation>Taruscio D, Vittozzi L, Rocchetti A, Torreri P, Ferrari L. The occurrence of 275 rare diseases and 47 rare disease groups in Italy. Results from the national registry of rare diseases. Int J Environ Res Public Health. (2018) 15:1470. 10.3390/ijerph15071470</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15071470</ArticleId><ArticleId IdType="pmc">PMC6068991</ArticleId><ArticleId IdType="pubmed">30002291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucato M, Pozza LVD, Minichiello C, Manea S, Barbieri S, Toto E, et al. . The epidemiology of transition into adulthood of rare diseases patients: results from a population-based registry. Int J Environ Res Public Health. (2018) 15:2212. 10.3390/ijerph15102212</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15102212</ArticleId><ArticleId IdType="pmc">PMC6210512</ArticleId><ArticleId IdType="pubmed">30309015</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone M, Kodra Y, Rocchetti A, Manno V, Minelli G, Gerussi A, et al. . Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy. Int J Environ Res Public Health. (2020) 4:3095. 10.3390/ijerph17093095</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17093095</ArticleId><ArticleId IdType="pmc">PMC7246900</ArticleId><ArticleId IdType="pubmed">32365682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliklich RE, Dreyer NA, Leavy MB, Christian JB. 21 st Century Patient Registries: Registries for Evaluating Patient Outcomes: A Users Guide: Addendum. Rockville, MD: Agency for Healthcare Research and Quality; (2018). 10.23970/AHRQREGISTRIESEBOOK</Citation><ArticleIdList><ArticleId IdType="doi">10.23970/AHRQREGISTRIESEBOOK</ArticleId><ArticleId IdType="pubmed">29708678</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Citters ADV, Morgan TS, et al. . Patient focused registries can improve health, care, and science. BMJ. (2016) 7:i3319. 10.1136/bmj.i3319</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i3319</ArticleId><ArticleId IdType="pmc">PMC5367618</ArticleId><ArticleId IdType="pubmed">27370543</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO; World Health Organization. 
WHO Guideline Recommendations on Digital Interventions for Health System Strengthening. (2019). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK541902/ (accessed March 17, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">31162915</ArticleId></ArticleIdList></Reference><Reference><Citation>Samad Z, Mahmood S, Siddiqui S, Bhutta ZA. Imagining a lean and agile digital health ecosystema measure of pandemic responsiveness. J Glob Health. (2020) 12:10. 10.7189/jogh.10.020391</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.10.020391</ArticleId><ArticleId IdType="pmc">PMC7719399</ArticleId><ArticleId IdType="pubmed">33312498</ArticleId></ArticleIdList></Reference><Reference><Citation>de Medeiros Valentim RA, Lima TS, Cortez LR, da Silva Barros DM, da Silva RD, de Paiva JC, et al. . A relevncia de um ecossistema tecnolgico no enfrentamento Covid-19 no Sistema nico de Sade: o caso do Rio Grande do Norte, Brasil. Cincia &amp; Sade Coletiva. (2021) 6:2035&#x2013;52. 10.1590/1413-81232021266.44122020</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1413-81232021266.44122020</ArticleId><ArticleId IdType="pubmed">34231717</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima Medeiros PA, da Silva GVS, dos Santos Fernandes FR, Snchez-Gendriz I, Lins HWC, da Silva Barros DM, et al. . Efficient machine learning approach for volunteer eye-blink detection in real-time using webcam. Expert Syst Appl. (2022) 2:116073. 10.1016/j.eswa.2021.116073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2021.116073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes F, Barbalho I, Barros D, Valentim R, Teixeira C, Henriques J, et al. . Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review. Biomed Eng Online. (2021) 20:61. 10.1186/s12938-021-00896-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12938-021-00896-2</ArticleId><ArticleId IdType="pmc">PMC8207575</ArticleId><ArticleId IdType="pubmed">34130692</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaiz F, Dourado MET, de Medeiros Valentim RA, de Morais AHF, Arrais JP. Machine learning solutions applied to amyotrophic lateral sclerosis prognosis: a review. Front Comp Sci. (2022) 4:4. 10.3389/fcomp.2022.869140</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcomp.2022.869140</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza AA, da Silva ST, de Medeiros Pondofe K, Resqueti VR, de Melo LP, de Medeiros Valentim RA, et al. . Remote vs. face-to-face home-based exercise programme in people with amyotrophic lateral sclerosis: protocol for a randomised clinical trial. BMJ Open. (2022) 5:e056323. 10.1136/bmjopen-2021-056323</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-056323</ArticleId><ArticleId IdType="pmc">PMC9137336</ArticleId><ArticleId IdType="pubmed">35618326</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbalho IMP, Fernandes F, Barros DMS, Paiva JC, Henriques J, Morais AHF, et al. . Electronic health records in Brazil: prospects and technological challenges. Front Public Health. (2022) 11:10. 10.3389/fpubh.2022.963841</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.963841</ArticleId><ArticleId IdType="pmc">PMC9669479</ArticleId><ArticleId IdType="pubmed">36408021</ArticleId></ArticleIdList></Reference><Reference><Citation>Pondofe K, Fregonezi GAF, Brito O, Jnior MED, Torres-Castro R, Resqueti VR, et al. . Effects of an optimised approach to home-based respiratory care in individuals with amyotrophic lateral sclerosis: a study protocol for a randomised controlled trial. BMJ Open. (2021) 11:e042780. 10.1136/bmjopen-2020-042780</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-042780</ArticleId><ArticleId IdType="pmc">PMC8043034</ArticleId><ArticleId IdType="pubmed">33837098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pondofe K, Marcelino AA, Ribeiro TS, Torres-Castro R, Vera-Uribe R, Fregonezi GA, et al. . Effects of respiratory physiotherapy in patients with amyotrophic lateral sclerosis: protocol for a systematic review of randomised controlled trials. BMJ Open. (2022) 5:e061624. 10.1136/bmjopen-2022-061624</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061624</ArticleId><ArticleId IdType="pmc">PMC9152929</ArticleId><ArticleId IdType="pubmed">35636801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripp D. Pesquisa-a ao: uma introdu ao metodol&#xf3;gica. Educaao e pesquisa. (2005) 31:443&#x2013;66. 10.1590/S1517-97022005000300009</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1517-97022005000300009</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwaber K. SCRUM development process. In:Sutherland J, Casanave C, Miller J, Patel P, Hollowell G, editors. Business Object Design and Implementation. London: Springer London; (1997). p. 117&#x2013;34.</Citation></Reference><Reference><Citation>Sindhwani R, Singh PL, Prajapati DK, Iqbal A, Phanden RK, Malhotra V. Agile system in health care: literature review. In:Shanker K, Shankar R, Sindhwani R, editors. Advances in Industrial and Production Engineering. Singapore: Springer Singapore; (2019). p. 643&#x2013;52. 10.1007/978-981-13-6412-9_61</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-6412-9_61</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil; Brasil. LEI N 13.709, DE 14 DE AGOSTO DE  (2018). Lei Geral de Proteo de Dados Pessoais (LGPD). Dirio Oficial [da] Repblica Federativa do Brasil. (2018). Available online at: http://www.planalto.gov.br/ccivil03/ato2015-2018/2018/lei/l13709.htm</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. (1999) 169:13&#x2013;21. 10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil . Projeto de Lei n 4691, de 2019. In: Senado Federal. (2019). Available online at: https://www25.senado.leg.br/web/atividade/materias/-/materia/138326 (accessed April 13, 2023).</Citation></Reference><Reference><Citation>Brasil; Ministrio da Sade . PORTARIA N 199, DE 30 DE JANEIRO DE (2014).In: Pol&#x2013;tica Nacional de Ateno Integral s Pessoas com Doens Raras- PNAIPDR. Dirio Oficial da Repblica Federativa do Brasil. (2014). Available online at: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2014/prt0199_30_01_2014.html (accessed April 13, 2023).</Citation></Reference><Reference><Citation>Brasil . LEI N 10.924, DE 10 DE JUNHO DE 2021. In: Dirio Oficial do Estado do Rio Grande do Norte. (2021). Available online at: http://diariooficial.rn.gov.br/dei/dorn3/docview.aspx?idjor=00000001&amp;data=20210611&amp;id_doc=726286 (accessed April 13, 2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>